关注
John E La Marca
John E La Marca
在 wehi.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Two-Faced: Roles of JNK Signalling During Tumourigenesis in the Drosophila Model
JE La Marca, HE Richardson
Frontiers in cell and developmental biology 8, 42, 2020
1212020
Drosophila Models of Cell Polarity and Cell Competition in Tumourigenesis
N Fahey-Lozano, JE La Marca, M Portela, HE Richardson
The Drosophila Model in Cancer, 37-64, 2019
252019
Strip and Cka negatively regulate JNK signalling during Drosophila spermatogenesis
JE La Marca, ST Diepstraten, AL Hodge, H Wang, AH Hart, ...
Development 146 (13), dev174292, 2019
192019
Rbf regulates Drosophila spermatogenesis via control of somatic stem and progenitor cell fate in the larval testis
N Dominado, JE La Marca, NA Siddall, J Heaney, M Tran, Y Cai, F Yu, ...
Stem cell reports 7 (6), 1152-1163, 2016
172016
A genome-wide Drosophila epithelial tumorigenesis screen identifies Tetraspanin 29Fb as an evolutionarily conserved suppressor of Ras-driven cancer
T Zoranovic, J Manent, L Willoughby, R Matos de Simoes, JE La Marca, ...
PLoS Genetics 14 (10), e1007688, 2018
142018
Phosphorylation of Drosophila Brahma on CDK-phosphorylation sites is important for cell cycle regulation and differentiation
SNA Roesley, JE La Marca, AJ Deans, L Mckenzie, R Suryadinata, ...
Cell Cycle 17 (13), 1559-1578, 2018
132018
Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugs
ST Diepstraten, S Young, JE La Marca, Z Wang, RM Kluck, A Strasser, ...
Cell Death & Differentiation 30 (4), 1005-1017, 2023
112023
Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
ST Diepstraten, Y Yuan, JE La Marca, S Young, C Chang, L Whelan, ...
Cancer Cell 42 (5), 850-868. e9, 2024
82024
PTP61F mediates cell competition and mitigates tumorigenesis
JE La Marca, LF Willoughby, K Allan, M Portela, PK Goh, T Tiganis, ...
International Journal of Molecular Sciences 22 (23), 12732, 2021
62021
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses
JE La Marca, BJ Aubrey, B Yang, C Chang, Z Wang, A Kueh, L Tai, ...
Cell Death & Differentiation 31 (2), 150-158, 2024
42024
The Drosophila gonads: models for stem cell proliferation, self-renewal, and differentiation
JE La Marca, WG Somers
AIMS Genetics 1 (01), 055-080, 2014
42014
A Drosophila chemical screen reveals synergistic effect of MEK and DGKα inhibition in Ras-driven cancer
JE La Marca, RW Ely, ST Diepstraten, P Burke, GL Kelly, PO Humbert, ...
Disease Models & Mechanisms 16 (3), dmm049769, 2023
22023
Don’t fear the reaper: The role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapy
JE La Marca, GL Kelly, A Strasser, ST Diepstraten
Developmental Cell 59 (19), 2532-2548, 2024
12024
Mouse models to investigate in situ cell fate decisions induced by p53
E Lieschke, AF Thomas, A Kueh, GK Atkin-Smith, PL Baldoni, ...
The EMBO journal 43 (19), 4406-4436, 2024
12024
BCL-W makes only minor contributions to MYC-driven lymphoma development
ST Diepstraten, JE La Marca, C Chang, S Young, A Strasser, GL Kelly
Oncogene 42 (37), 2776-2781, 2023
12023
Awakening the Genome: CRISPR Activation to Unravel the Origin and Vulnerabilities of Cancer
JE La Marca, ST Diepstraten, GL Kelly, MJ Herold
Annual Review of Cancer Biology 9, 2024
2024
The Drosophila tumour suppressor Lgl and Vap33 activate the Hippo pathway through a dual mechanism
M Portela, S Mukherjee, S Paul, JE La Marca, LM Parsons, A Veraksa, ...
Journal of Cell Science 137 (4), 2024
2024
Principles for Understanding Mechanisms of Cell Death and Their Role in Cancer Biology
ST Diepstraten, JE La Marca, DCS Huang, and, GL Kelly
Precision Cancer Therapies, Volume 1‐Targeting Oncogenic Drivers and …, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–18